Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma

    In-field high-grade glioma (HGG) recurrence is a common challenge with limited treatment options, including re-irradiation. The radiotracer 3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (18F-DOPA) crosses the bloo...

    William G. Breen, Ryan S. Youland, Sharmila Giri in Journal of Neuro-Oncology (2022)

  2. No Access

    Article

    Dose-escalated accelerated hypofractionation for elderly or frail patients with a newly diagnosed glioblastoma

    The standard of care for elderly glioblastoma patients is 40 Gy in 15 fraction radiotherapy with temozolomide (TMZ). However, this regimen has a lower biologic equivalent dose (BED) compared to the Stupp regim...

    Haley K. Perlow, Alexander Yaney, Michael Yang, Brett Klamer in Journal of Neuro-Oncology (2022)

  3. No Access

    Article

    The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience

    To clarify the role of stereotactic radiosurgery (SRS) for atypical meningiomas (AM).

    Hirotaka Hasegawa, Kunal Vakharia, Michael J. Link in Journal of Neuro-Oncology (2021)

  4. No Access

    Article

    Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy

    To clarify the need for post-operative radiation treatment in skull base chondrosarcomas (SBCs).

    Hirotaka Hasegawa, Kunal Vakharia, Christopher S. Graffeo in Journal of Neuro-Oncology (2021)

  5. No Access

    Article

    Prescription of memantine during non-stereotactic, brain-directed radiation among patients with brain metastases: a population-based study

    Whole brain radiation therapy (WBRT) remains an important component of treatment for patients with multiple brain metastases (BrM) but is associated with significant neurotoxicity and memory impairment. Althou...

    Nayan Lamba, Elie Mehanna, Rachel B. Kearney, Paul J. Catalano in Journal of Neuro-Oncology (2020)

  6. No Access

    Article

    Brain metastases resection cavity radio—surgery based on T2-weighted MRI: technique assessment

    Stereotactic radiosurgery (SRS) is commonly performed after surgical resection of brain metastases to reduce the chance of local tumor recurrence while maintaining cognitive function. Target delineation in the...

    Achiraya Teyateeti, Paul D. Brown, Anita Mahajan in Journal of Neuro-Oncology (2020)

  7. No Access

    Article

    Assembling the brain trust: the multidisciplinary imperative in neuro-oncology

    Ethan B. Ludmir, Anita Mahajan, Verity Ahern in Nature Reviews Clinical Oncology (2019)

  8. Article

    Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

    The last author's first name was truncated in the initial online publication. The original article has been corrected.

    Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon in Journal of Neuro-Oncology (2019)

  9. No Access

    Article

    Breast cancer subtype and intracranial recurrence patterns after brain-directed radiation for brain metastases

    Brain metastases from breast cancer are frequently managed with brain-directed radiation but the impact of subtype on intracranial recurrence patterns after radiation has not been well-described. We investigat...

    Daniel N. Cagney, Nayan Lamba, Sofia Montoya in Breast Cancer Research and Treatment (2019)

  10. No Access

    Article

    Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

    To evaluate the pharmacokinetics and efficacy of imatinib in patients with recurrent oligodendroglial tumors.

    Kurt A. Jaeckle, S. K. Anderson, Erin L. Twohy, Jesse G. Dixon in Journal of Neuro-Oncology (2019)

  11. No Access

    Article

    Local control after brain-directed radiation in patients with cystic versus solid brain metastases

    Brain metastases can be radiographically cystic or solid. Cystic metastases are associated with a greater intracranial disease burden and poorer oncologic outcomes, but the impact of cystic versus solid appear...

    Rachel H. Brigell, Daniel N. Cagney, Allison M. Martin in Journal of Neuro-Oncology (2019)

  12. No Access

    Article

    Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy

    Studies on melanoma brain metastases (MBM) with regard to mutational status are lacking. We investigated the outcomes of MBM in molecularly characterized patients for BRAF and NRAS mutations receiving conventiona...

    Penny Fang, Nicholas S. Boehling, Eugene J. Koay in Journal of Neuro-Oncology (2018)

  13. No Access

    Article

    The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma

    Despite recent randomized, prospective evidence supporting use of RT and chemotherapy (CRT) for high-risk low-grade gliomas (LGG), many patients have historically received RT alone, chemotherapy alone or obser...

    Ryan S. Youland, Cole R. Kreofsky, David A. Schomas in Journal of Neuro-Oncology (2017)

  14. No Access

    Article

    Neurocognition in individuals with incidentally-identified meningioma

    Meningiomas are primary intracranial tumors that are often asymptomatic. To our knowledge, no study has attempted to describe neurocognitive function in patients with incidentally-discovered meningioma. We uti...

    Alissa M. Butts, Stephen Weigand, Paul D. Brown in Journal of Neuro-Oncology (2017)

  15. No Access

    Article

    Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience

    The purpose of this study was to identify changes in presentation, treatment and outcomes of older patients with low-grade glioma (LGG) over the past 50 years. 94 adults aged 55 or older upon diagnosis of a WH...

    Ryan S. Youland, David A. Schomas, Paul D. Brown in Journal of Neuro-Oncology (2017)

  16. No Access

    Article

    Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials

    The aim of this study was to determine the predictability of vertebral compression fracture (VCF) development applying the spinal instability neoplastic score (SINS) prior to delivery of stereotactic spinal ra...

    Sun-Ho Lee, Claudio E. Tatsui, Amol J. Ghia, Behrang Amini in Journal of Neuro-Oncology (2016)

  17. No Access

    Article

    Exploring primary brain tumor patient and caregiver needs and preferences in brief educational and support opportunities

    A primary brain tumor patient and caregiver survey was completed to investigate interest in brief support opportunities, focused on education, memory training, and healthy co**, during a routine clinical vis...

    Sarah K. Lageman, Paul D. Brown, S. Keith Anderson in Supportive Care in Cancer (2015)

  18. No Access

    Article

    Supratentorial gross-totally resected non-anaplastic ependymoma: population based patterns of care and outcomes analysis

    Observation following gross-total resection (GTR) for non-anaplastic supratentorial ependymomas is often advocated based on small, retrospective series. The purpose of this study is to perform a population-bas...

    Amol J. Ghia, Anita Mahajan, Pamela K. Allen in Journal of Neuro-Oncology (2013)

  19. No Access

    Article

    The effect of tumor subtype on the time from primary diagnosis to development of brain metastases and survival in patients with breast cancer

    Our group has previously published the Diagnosis-Specific Graded Prognostic Assessment (GPA) showing the prognostic factors associated with survival in patients with brain metastases (BM). The purpose of this ...

    Paul W. Sperduto, Norbert Kased, David Roberge, Samuel T. Chao in Journal of Neuro-Oncology (2013)

  20. No Access

    Article

    Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice

    The purpose of this study is to determine the factors that impact overall survival (OS) in adult patients with gliosarcoma in the modern era treated at a single institution compared with a cohort from the SEER...

    Gary V. Walker, Mark R. Gilbert, Sujit S. Prabhu in Journal of Neuro-Oncology (2013)

previous disabled Page of 2